GgoogleUS first seen 6 d ago, last 6 d ago, peak #4
Artiva halts cell therapy after two patient deaths
Original: artiva
Artiva Biotherapeutics is discontinuing its cell therapy program after two patient deaths in trials, Reuters reports. The company will also cut its workforce by 94%, a drastic downsizing that effectively winds down its main pipeline. The deaths and near-total staff reduction make the survival of the clinical-stage biotech highly uncertain.
Why now: Two patient deaths and a 94% workforce cut are dramatic news for a clinical-stage biotech, raising questions about trial safety and the company's future.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/3988562